Updated Functional Classification of β-Lactamases
By K. Bush, G. Jacoby. Antimicrobial Agents and Chemotherapy, 2009
1,978 citations recorded by the source corpus.
ABSTRACT Two classification schemes for β-lactamases are currently in use. The molecular classification is based on the amino acid sequence and divides β-lactamases into class A, C, and D enzymes which utilize serine for β-lactam hydrolysis and class B metalloenzymes which require divalent zinc ions for substrate hydrolysis. The functional classification scheme updated herein is based on the 1995 proposal by Bush et al. (K. Bush, G. A. Jacoby, and A. A. Medeiros, Antimicrob. Agents Chemother. 39:1211-1233, 1995). It takes into account substrate and inhibitor profiles in an attempt to group the enzymes in ways that can be correlated with their phenotype in clinical isolates. Major groupings generally correlate with the more broadly based molecular classification. The updated system includes group 1 (class C) cephalosporinases; group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and extended-spectrum β-lactamases and serine carbapenemases; and group 3 metallo-β-lactamases. Several new subgroups of each of the major groups are described, based on specific attributes of individual enzymes. A list of attributes is also suggested for the description of a new β-lactamase, including the requisite microbiological properties, substrate and inhibitor profiles, and molecular sequence data that provide an adequate characterization for a new β-lactam-hydrolyzing enzyme.
Subfields: Applied Microbiology and Biotechnology, Epidemiology, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/3d58e223b0809a31106d01ff6a05716c70c4d88d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
- W. Reygaert
- P. Bradford
- K. Bush
- J. Pitout
- L. Serwecińska
- P. Nordmann
- Gerard D. Wright
- Robert A. Bonomo
In Epidemiology
In Molecular Medicine
Citations in the corpus
- Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens (2016, background): “These bacteria are common causes of life-threatening nosocomial infections amongst critically ill and immunocompromised individuals and are characterized by potential drug resistance mechanisms [5].”
- Epidemiology of β-Lactamase-Producing Pathogens (2020, methodology): “subgroups of class A, class C, and class D enzymes (39).”
- Carbapenems: Past, Present, and Future (2011, background): “Many class A β-lactamases are susceptible to 11 inhibition by clavulanic acid (26).”
- The Comprehensive Antibiotic Resistance Database (2013, background): “org /Studies/) (24) is exclusively focused on compiling an inventory of a functional subset of antibiotic resistance genes, ResFinder (cge.”
- Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health (2020, background): “Firstly, they produce an extended spectrum of β-lactamases (ESBLs) that confer resistance to such antimicrobials as cephalosporins, penicillins, and monobactams, and they include a growing number of carbapenem-resistant strains; all of these are new-generation antibiotics that are employed as “the l”
- Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance (2017, background): “Since their introduction, hundreds of different β-lactamases have evolved among enteric pathogens including K. pneumoniae, reaching an astonishing number (>2000) and diversity (Bush and Jacoby 2010).”
- Acquired Antibiotic Resistance Genes: An Overview (2011, background): “…at their active site, whereas Ambler class B β-lactamases are all metallo-enzymes who require zinc as a metal cofactor for their catalytic activities (Ambler, 1980; Bradford, 2001; Paterson and Bonomo, 2005; Wright, 2005; Poirel et al., 2007, 2010; Bush and Jacoby, 2010; Drawz and Bonomo, 2010).”
- Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae (2018, background): “…in K. pneumoniae can be mediated in part through up-regulation of efflux pumps (Filgona et al., 2015) and alteration of outer membrane porins in the core genome (Kaczmarek et al., 2006), and hyperproduction of ESBL enzymes or AmpC β-lactamases in the accessory genome (Bush and Jacoby, 2010).”